UK Stomach Cancer Consultants

Dr Charlotte Rees is a Consultant Medical Oncologist based at University Hospital Southampton, where she is the lead for chemotherapy.

Charlotte completed specialist training in medical oncology at The Royal Marsden Hospital between 1996 and 2003. She was also actively involved in the recruitment of patients to phase I to III clinical trials throughout her training and while working for the Institute of Cancer Research at Sutton she was involved in the phase I trials unit.

Dr Rees worked as a consultant in medical oncology and was honorary lecturer at St George’s Hospital, Tooting, London, from 2003 to 2005.

Dr Rees sits on the National Specialist Advisory Committee for Medical Oncology. She is the training programme director for medical oncology for the Wessex deanery and has a Medical Research Council scholarship for BSc in pharmacology. 

Dr Rees is a member of network chemotherapy group and a member of network upper gastrointestinal cancers network group.

Dr Andrew Gaya is a Consultant Clinical Oncologist based at Guy's and St. Thomas' NHS Foundation Trust.

Dr Gaya originally qualified at St George’s Hospital Medical School (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London.

Dr Gaya treats solid tumours using chemotherapy, radiotherapy, and biological therapy – His main focus is on colorectal cancer, cancers of the oesophagus, stomach, pancreas, liver, and lung cancer. Dr Gaya’s main research interest is in the area of functional cancer imaging, where he is looking for ways to assess response to treatment much earlier and techniques for assessing blood flow and oxygen levels within cancers.

He is also heavily involved with the implementation of the latest radiotherapy techniques such as IMRT, IGRT and Tomotherapy, combining targeted or anti-vascular drugs with radiotherapy, and stereotactic body radiosurgery. He is one of the first UK doctors to use the CyberKnife stereotactic body radiosurgery unit. He has published widely in peer-reviewed journals, and is currently lead clinical oncologist for audit and clinical governance at Guy’s and St Thomas’ NHS Foundation Trust.

Dr Iveson is a Consultant Medical Oncologist based at University Hospital Southampton NHS Foundation Trust and Salisbury NHS Foundation Trust.  He works at both Southampton and Salisbury.

He specialises in the chemotherapy treatment of gastro-intestinal cancers (oesophagus, stomach, pancreas, and bowel cancer).

He is an active participant in clinical trials trying to improve the treatment for these cancers and has published widely on the treatment of gastro-intestinal cancers.

He is the chief investigator of the SCOT study looking at the duration of adjuvant chemotherapy treatment. 

He is a member of the NCRI (National Cancer Research Institute) Colorectal Cancer Adjuvant and Advanced Disease Sub-group. He is a member of the Medical Advisory Board of Bowel Cancer UK and the Clinical Advisory Board for Macmillan Cancer Support.

He believes that patients should be well informed about their cancer and its treatment and therefore should have access to high quality patient information. For many years he has worked with Macmillan Cancer Support and now is their Chief Medical Editor overseeing the information in their booklets and on their website.

Dr Hosney Yosef is a Consultant Clinical Oncologist based at the Beastson West of Scotland Cancer Centre.

Dr Yosef qualified from the University of Cairo Medical School in 1965 and has practised for over 30 years at the Beatson. He has played a leading role in the development of services with radiotherapy and chemotherapy, particularly in breast and gastrointestinal cancer as well as head and neck malignancy. 

Dr Yosef has developed specialised expertise in breast cancer, head and neck cancer, and gastrointestinal malignancy (both upper GI and colorectal). He has served as a member of the Medical Research Council, the Faculty Board for Clinical Oncology of the Royal College of Radiologists, the Council and Oncology Committee of the British Institute of Radiology (Chairman), The West of Scotland Managed Clinical Network and the Scottish Intercollegiate Guidelines Network (SIGN) Scottish Audit Group. Previously he was President, Secretary and Member of the Council of the Scottish Radiological Society.

Dr Was Mansoor is a Consultant Medical Oncologist at The Christie NHS Foundation Trust in Manchester.  He is cuurently the Clinical Director of Medical Oncology at The Christie.

Dr Mansoor moved to Manchester in 1998 to take up his career in Medical Oncology. During his training, he researched the relationship between cancer (in particular upper GI cancers) and the immune system and attained a PhD based on this research. Dr Mansoor continued his service and research interests into upper GI cancers, neuroendocrine cancers and other rare cancers when he became a consultant at The Christie in 2006. He also has an interest in developing medical education and became the Training Programme Director for Medical Oncology in 2009 to develop medical education.

Dr Mansoor is now the head of the oesphagogastric department, where he and his team provide a specialised service to  patients, incorporating access to many cutting edge trials.

Dr Mansoor speaks English, Urdu and Punjabi.

Dr Stephen Falk is a Consultant Clinical Oncologist based at The Bristol Haematology and Oncology Centre.

Dr Falk's major clinical interest is gastro-intestinal cancer (oesophagus, stomach, pancreas, colo-rectal).

Dr Falk qualified from Liverpool University in 1983 and spent a period in Liverpool undertaking a general medical rotation.  He then trained in oncology in Cardiff and Cambridge becoming a consultant in Bristol in 1994.

He has  sessional commitments to Southmead Hospital Bristol and attends the Taunton Nuffield hospital.  Stephen is  Clinical director of the West of England Local Research network whose job is to fund the NHS costs of delivering research activity in the NHS. He is also a member of the NCRI upper GI studies group, and chairs the pancreatic sub group.  He is a member of the editorial board of the Journal Clinical Oncology, and an author in more than 50 publications.

Dr Simon Gollins is a Consultant Clinical Oncologist based at The North Wales Cancer Treatment Centre, Glan Clwyd.

Dr Gollins qualified in medicine in 1988 at the University of Oxford, where he also carried out 3 years of laboratory research for a Doctor of Philosophy degree (PhD). Following medical jobs in Bath and Birmingham he gained his Membership of the Royal College of Physicians in 1991.

His oncology training took place at the Christie Hospital Manchester where he gained his Fellowship of the Royal College of Radiologists in 1994 and at Velindre Hospital Cardiff where he was also a Consultant Clinical Oncologist prior to moving to North Wales.

Dr Hamid Sheikh is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust in Manchester.

Dr Sheikh took his position at Christie Hospital Foundation Trust in 2009 and is the Clinical Oncology Lead for upper GI cancer. Also at The Christie he is involved in UK research trials.

Dr Sheikh covers Lung Cancer services for the populations of Salford and East Cheshire and surrounding areas and offers intra-luminal brachytherapy service for treating tumours in airways.

Dr Sheikh speaks multiple lanuages including English, Urdu, Hindi.

Dr Richard Hubner is a Consultant Medical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Dr Hubner received undergraduate medical training at Cambridge and Oxford Universities, and completed specialist training in medical oncology at the Royal Marsden Hospital.

Richard performed research into genetic susceptibility to cancer leading to a PhD, and this and other research has led to a number of publications in peer-reviewed medical journals and presentations at national and international meetings. Dr Hubner has been a consultant at the Christie Hospital since 2010.